WO1992015599A1 - OLIGOSIALYL-1,2-DIALKYL-Sn-GLYCEROL AND INTERMEDIATE FOR ITS SYNTHESIS - Google Patents
OLIGOSIALYL-1,2-DIALKYL-Sn-GLYCEROL AND INTERMEDIATE FOR ITS SYNTHESIS Download PDFInfo
- Publication number
- WO1992015599A1 WO1992015599A1 PCT/JP1992/000249 JP9200249W WO9215599A1 WO 1992015599 A1 WO1992015599 A1 WO 1992015599A1 JP 9200249 W JP9200249 W JP 9200249W WO 9215599 A1 WO9215599 A1 WO 9215599A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- independently
- compound
- oligosialyl
- glycerol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Definitions
- the present invention relates to an oligosialyl-1,2-dialkyl-1-Sn-glycerol and a synthetic intermediate thereof. More specifically, the present invention relates to 2 ⁇ 8 oligosialyl-1,2, -dialkylyl Sn-glycerol, a synthetic intermediate thereof, and methods for producing these. Background art
- the capsular polysaccharide isolated from (Neisseria meningitidis Serotype C) consists of a single polymer of 2 ⁇ 9 bonds of N-acetylneurasic acid, and is partially (8th or 9th) 0-acetylinole Structure confirmed by 13 C NMR
- capsular polysaccharide isolated from Escherichia coli Bos 12 is also a heteropolymer having both ⁇ 2 ⁇ 9 and ⁇ 2 ⁇ 8 binding modes, and Escherichia coli 1 It has been reported that capsular polysaccharides isolated from (Escherichia coli K1) are homopolymers having a binding mode of 2 ⁇ 8 (W. Bgan, TY Lui, D. Dorow, JS Cohem, JD Robine) , EC Gotschlich, JB Robins, Biochemistry, 163687-92 (1977)).
- polysaccharides produced by bacteria have been found to have an activity such as enhancement of immune activity and antitumor activity (EC Gotschlich, BA Franser, ON Shimura, JB Robbins, TY Lui, J. Biol, Chem., 256 8915-8921 (1981)).
- an object of the present invention is to provide oligosaccharide 1,2-dialkyl-1-Sn-glycerone monooleate, which is a derivative of oligogalinoleic acid, and a synthetic intermediate thereof. Furthermore, the present invention also provides a method for producing oligosialyl-1,2-dialkyl-1-Sn-glycerol. Disclosure of the invention
- oligosialic acid which was synthesized stereoselectively by condensation of a sialic acid sugar donor with an auxiliary group at the 3-position and an appropriately protected sialic acid sugar acceptor.
- oligosialyl-1,1,2-dialkyl-1-Sn-glycerol was successfully produced, and the present invention was completed. That is, the present invention provides a compound of the formula (I):
- Oligosialyl 1, 1 dianolealkyl 1 Sn-glycerol represented by the formula (II) and (III):
- Oligosialyl-1,2-dialkyl-Sn-glyceronole synthetic intermediate represented by And formula (IV):
- R 1 independently represents a group selected from the group consisting of a hydrogen atom and an alkali metal. Of these, arsenic and sodium are preferred.
- R 2 independently represents an alkyl group having 14 to 18 carbon atoms. Among them, an alkyl group having 14 carbon atoms is preferable.
- R 11 in the formulas (II) and (IV) and R 21 in the formula (III) each independently represent a group selected from the group consisting of a thiophenyl group and a selenylphenyl group. Of these, a thiophenyl group is preferred.
- R 12 in the formulas (II) and (IV) and R 22 in the formula (III) each independently represent a propyloxyl group which may be protected.
- the protecting group include a methyl group, a benzyl group, and an aryl group, but are not limited thereto, and can be appropriately selected within a range obvious to those skilled in the art. Of these, a methyl group is preferred.
- R 13 in the formulas (II) and (IV) and R 23 in the formula (III) each independently represent a hydroxyl group which may be protected.
- examples of the protecting group include a benzyloxy group, an acetinoleoxy group, and a triphenylmethyloxy group, but are not limited thereto, and can be appropriately selected within a range obvious to those skilled in the art. Of these, a benzyloxy group is preferred.
- X represents a halogen atom that is a fluorine atom, a chlorine atom, an iodine atom, or an iodine atom. Of these, chlorine atomic is preferable.
- ⁇ in the formulas ( ⁇ ) to (IV) represents an integer of 0 to 20. Of these, 0 to 1 is preferred.
- the condensing di ⁇ Honoré kill glycerol compound of the formula (V) of the formula (IV), as a condensing agent, Hg (CN) 2 -3 ⁇ 4Br 2 AgOTf, Cp 2 HfCl 2 -AgOTf, Cp 2 ZrCl 2 - AgOTf etc. can be selected. Of these, Hg (CN) 2 -HgBr 2 is preferred.
- the above condensation reaction is carried out in a solvent such as carbon tetrachloride, dichloromethane, 1,2-dichloroethane, or acetonitrile for 4 to 18 hours at 120 ° C. to room temperature at 76 OnimHg (normal pressure). be able to.
- the condensation is carried out in a solvent of carbon tetrachloride at ⁇ 20 ° C. to room temperature for 4 to 18 hours at ⁇ 76 ° C. to room temperature. Perform a combined reaction.
- reaction solution was subjected to cerite filtration, and the filtrate was washed successively with a 10% potassium iodide solution, a saturated sodium bicarbonate solution, and a saturated saline solution.
- the organic layer was dried over magnesium sulfate, the solvent was distilled off, and the residue was purified by gel filtration with SX-3 (toluene) to obtain Compound 12 (9 lmg, 41). (9 mg, 74%).
- reaction solution was diluted with ethyl acetate, washed successively with (NHC1 aqueous solution, saturated aqueous sodium hydrogen carbonate, and saturated saline.
- the polysaccharide containing cyanoleic acid can be efficiently produced using the oligosialyl-1,1,2-dialkyl-1-Sn-glyceronolate synthetic intermediate of the present invention.
- the sialic acid-containing polysaccharides produced by the oligosialyl-1,2, -dianolyl-1Sn-glycerol of the present invention and the oligosialyl-1,1,2-dialkyl-1Sn-daliceronol synthetic intermediate of the present invention are characterized by an immunoactive agent, an antitumor It is a useful compound that can be used as an agent, a diagnostic agent for cancer and a therapeutic agent.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Crystallography & Structural Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP92906226A EP0640613A1 (en) | 1991-03-04 | 1992-03-03 | OLIGOSIALYL-1,2-DIALKYL-Sn-GLYCEROL AND INTERMEDIATE FOR ITS SYNTHESIS |
US08/108,672 US5470962A (en) | 1991-03-04 | 1993-09-07 | Oligosialyl-1,2-dialkyl-sn-glycerols and synthetic intermediates for their preparation |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP03037594A JP3110474B2 (ja) | 1991-03-04 | 1991-03-04 | オリゴシアリル−1,2−ジアルキル−Sn−グリセロール及びその合成中間体 |
JP3/37594 | 1991-03-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1992015599A1 true WO1992015599A1 (en) | 1992-09-17 |
Family
ID=12501880
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1992/000249 WO1992015599A1 (en) | 1991-03-04 | 1992-03-03 | OLIGOSIALYL-1,2-DIALKYL-Sn-GLYCEROL AND INTERMEDIATE FOR ITS SYNTHESIS |
Country Status (4)
Country | Link |
---|---|
US (1) | US5470962A (ja) |
EP (1) | EP0640613A1 (ja) |
JP (1) | JP3110474B2 (ja) |
WO (1) | WO1992015599A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6627794B1 (en) | 1995-05-23 | 2003-09-30 | Commonwealth Scientific And Industrial Research Organisation | Polyphenyl oxidase genes from banana |
US7381810B2 (en) | 1995-05-23 | 2008-06-03 | Commonwealth Scientific And Industrial Research Organistion | Polyphenol oxidase genes from lettuce |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03146503A (ja) * | 1989-11-01 | 1991-06-21 | Dai Ichi Kogyo Seiyaku Co Ltd | トウモロコシ澱粉粕のカルボキシメチルエーテル塩の製造方法 |
JP3062906B2 (ja) * | 1993-01-29 | 2000-07-12 | 丸金醤油株式会社 | N−アセチルノイラミン酸ホモポリマーの硫酸エステル |
CN107955079B (zh) * | 2017-11-08 | 2020-05-01 | 江南大学 | 双聚唾液酸仿生材料及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59164798A (ja) * | 1983-03-09 | 1984-09-17 | Rikagaku Kenkyusho | シアル酸含有糖脂質誘導体 |
JPS62273992A (ja) * | 1986-05-21 | 1987-11-28 | Nippon Zoki Pharmaceut Co Ltd | 新規シアル酸誘導体 |
-
1991
- 1991-03-04 JP JP03037594A patent/JP3110474B2/ja not_active Expired - Fee Related
-
1992
- 1992-03-03 WO PCT/JP1992/000249 patent/WO1992015599A1/ja not_active Application Discontinuation
- 1992-03-03 EP EP92906226A patent/EP0640613A1/en not_active Ceased
-
1993
- 1993-09-07 US US08/108,672 patent/US5470962A/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59164798A (ja) * | 1983-03-09 | 1984-09-17 | Rikagaku Kenkyusho | シアル酸含有糖脂質誘導体 |
JPS62273992A (ja) * | 1986-05-21 | 1987-11-28 | Nippon Zoki Pharmaceut Co Ltd | 新規シアル酸誘導体 |
Non-Patent Citations (2)
Title |
---|
See also references of EP0640613A4 * |
Tetrahedron, Vol. 46, No. 1, pages 89 to 102, 1990, T. OGAWA et al., "Highly Stereoselective Glycosylation of Sialic acid Aided by Stereocontrolling Auxiliares". * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6627794B1 (en) | 1995-05-23 | 2003-09-30 | Commonwealth Scientific And Industrial Research Organisation | Polyphenyl oxidase genes from banana |
US7381810B2 (en) | 1995-05-23 | 2008-06-03 | Commonwealth Scientific And Industrial Research Organistion | Polyphenol oxidase genes from lettuce |
Also Published As
Publication number | Publication date |
---|---|
US5470962A (en) | 1995-11-28 |
JP3110474B2 (ja) | 2000-11-20 |
JPH04275295A (ja) | 1992-09-30 |
EP0640613A1 (en) | 1995-03-01 |
EP0640613A4 (en) | 1994-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CZ295406B6 (cs) | Způsob výroby tetraazamakrocyklických sloučenin | |
WO1992015599A1 (en) | OLIGOSIALYL-1,2-DIALKYL-Sn-GLYCEROL AND INTERMEDIATE FOR ITS SYNTHESIS | |
FI87573B (fi) | Foerfarande foer framstaellning av gangliosidlika foereningar | |
US6030959A (en) | Gastro-specific prodrugs | |
EP0060999A1 (de) | Galactopyranoside Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als Antigene oder Immunadsorbentien | |
JP3688337B2 (ja) | ピリピロペン誘導体 | |
WO1990013554A1 (fr) | Procede de production de derives de ferrocenoyle | |
Yu et al. | A novel and efficient deprotection of the allyl group at the anomeric oxygen of carbohydrates | |
US5693770A (en) | Process for the manufacture of 3-amino-substituted glycosylated bile acids | |
JP3717962B2 (ja) | グリセロ糖脂質化合物の製造法 | |
JP3051213B2 (ja) | マルトオリゴ糖誘導体、その合成中間体及びその製造方法 | |
JPH0635467B2 (ja) | 新規なグリコシル化方法 | |
US5861437A (en) | Polyphenylene ether resin | |
EP2121724B1 (fr) | Nouveau procede pour l'obtention diastereoselective d'une amine primaire chirale sur un steroïde | |
JP2009527537A (ja) | マンノシル−1ホスフェート、その製造方法および特にCDG−Ia症候群の治療方法 | |
JP3772204B2 (ja) | 糖鎖誘導体及びその製造方法 | |
Laurent et al. | Syntheses of α-d-galactosamine neoglycolipids | |
JPH064669B2 (ja) | ポリエン物質及び肥満細飽機能調節剤 | |
JP3069824B2 (ja) | 2−クロロ−4−ニトロフェニル−α−D−マルトトリオシドの製造方法 | |
JP2006083091A (ja) | トレハロース型二糖類及びその誘導体の製造方法並びに新規トレハロース型二糖類誘導体 | |
JPS6140669B2 (ja) | ||
JP3134010B2 (ja) | デスアラニンベナノマイシンa誘導体およびそれらの製造法 | |
JPH05140202A (ja) | 環状オリゴ糖、その製造方法及び合成中間体 | |
JPS6328073B2 (ja) | ||
JPS6219598A (ja) | 2,3,2′,3′−テトラ−O−アルキル−α,α−トレハロ−ス誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1992906226 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 08108672 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1992906226 Country of ref document: EP |
|
WWR | Wipo information: refused in national office |
Ref document number: 1992906226 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1992906226 Country of ref document: EP |